Kush Parmar
10% Owner; Director; Director, 10% Owner · 8 filings · Latest: Sep 22, 2026
Camp4 Therapeutics Corp
Entrada Therapeutics, Inc.
Latigo Biotherapeutics, Inc.
Skye Bioscience, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
SKYE | Kush Parmar | 10% Owner | Sep 23, 2026 | Sale | $1.61 | 119,379 | $192.2K | 0 | |
SKYE | Kush Parmar | 10% Owner | Sep 22, 2026 | Sale | $1.65 | 28,700 | $47.4K | 4,528 | |
SKYE | Kush Parmar | 10% Owner | Sep 16, 2026 | Sale | $1.91 | 33,892 | $64.7K | 5,616 | |
SKYE | Kush Parmar | 10% Owner | Aug 20, 2026 | Sale | $0.32 | 7,700 | $2.5K | 7,850,155 | |
SKYE | Kush Parmar | 10% Owner | Aug 19, 2026 | Sale | $0.35 | 68,140 | $23.8K | 7,856,650 | |
SKYE | Kush Parmar | 10% Owner | Aug 18, 2026 | Sale | $0.38 | 300,000 | $114.0K | 7,914,126 | |
TRDA | Kush Parmar | Director | Aug 10, 2026 | Sale | $7.00 | 92,444 | $647.1K | 2,691,337 | |
TRDA | Kush Parmar | Director | Aug 7, 2026 | Sale | $6.85 | 52,317 | $358.4K | 2,783,781 | |
TRDA | Kush Parmar | Director | Aug 6, 2026 | Sale | $7.00 | 10,494 | $73.5K | 2,836,098 | |
TRDA | Kush Parmar | Director, 10% Owner | Jul 31, 2026 | Sale | $6.85 | 1,718 | $11.8K | 2,846,592 | |
TRDA | Kush Parmar | Director, 10% Owner | Jul 30, 2026 | Sale | $6.93 | 114,756 | $795.3K | 2,848,310 |